Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Spoendlin

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Journal of the American Heart Association|July 14, 2025
Risk of Acute Infections in New Users of Antihypertensive Drugs: An Observational Cohort StudyNoah Aebi, Christoph R Meier, Susan S Jick, et al.
Osteoarthritis and Cartilage Open|April 21, 2026
The risk of acute thromboembolic cardiovascular events in association with use of chondroitin sulphate: A comparative, propensity score-matched cohort study using Swiss healthcare claims dataTamino Zappalà, Theresa Burkard, Carola A Huber, et al.
Inflammatory Bowel Diseases|December 31, 2015
Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control StudyJulia Spoendlin, Gülistan Karatas, Raoul I Furlano, et al.
Dermatology (Basel, Switzerland)|July 10, 2025
Topical Drug Treatment of Rosacea in Switzerland: A Descriptive Study Using Swiss Claims DataTamino Zappalà, Alexander A Navarini, Carola A Huber, et al.
The Journal of Investigative Dermatology|December 24, 2017
Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control StudyNoel Frey, Andreas Bircher, Michael Bodmer, et al.
Journal of the American Academy of Dermatology|November 2, 2017
Evidence-based update on rosacea comorbidities and their common physiologic pathwaysAnna D Holmes, Julia Spoendlin, Anna L Chien, et al.
Pharmacoepidemiology and Drug Safety|November 22, 2016
Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research DatalinkNoel Frey, Andreas Bircher, Michael Bodmer, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational Cross-Sectional StudyCarole A Marxer, Marlene Rauch, Clementina Lang, et al.
Drug Safety|August 17, 2018
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control StudyNoel Frey, Michael Bodmer, Andreas Bircher, et al.
Pharmacoepidemiology and Drug Safety|September 3, 2024
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims DataTamino Zappalà, Anton Pottegård, Carola A Huber, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Journal of the American Heart Association|July 14, 2025
Risk of Acute Infections in New Users of Antihypertensive Drugs: An Observational Cohort StudyNoah Aebi, Christoph R Meier, Susan S Jick, et al.
Osteoarthritis and Cartilage Open|April 21, 2026
The risk of acute thromboembolic cardiovascular events in association with use of chondroitin sulphate: A comparative, propensity score-matched cohort study using Swiss healthcare claims dataTamino Zappalà, Theresa Burkard, Carola A Huber, et al.
Inflammatory Bowel Diseases|December 31, 2015
Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control StudyJulia Spoendlin, Gülistan Karatas, Raoul I Furlano, et al.
Dermatology (Basel, Switzerland)|July 10, 2025
Topical Drug Treatment of Rosacea in Switzerland: A Descriptive Study Using Swiss Claims DataTamino Zappalà, Alexander A Navarini, Carola A Huber, et al.
The Journal of Investigative Dermatology|December 24, 2017
Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control StudyNoel Frey, Andreas Bircher, Michael Bodmer, et al.
Journal of the American Academy of Dermatology|November 2, 2017
Evidence-based update on rosacea comorbidities and their common physiologic pathwaysAnna D Holmes, Julia Spoendlin, Anna L Chien, et al.
Pharmacoepidemiology and Drug Safety|November 22, 2016
Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research DatalinkNoel Frey, Andreas Bircher, Michael Bodmer, et al.
International Journal of Environmental Research and Public Health|July 9, 2022
Recording of Chronic Diseases and Adverse Obstetric Outcomes during Hospitalizations for a Delivery in the National Swiss Hospital Medical Statistics Dataset between 2012 and 2018: An Observational Cross-Sectional StudyCarole A Marxer, Marlene Rauch, Clementina Lang, et al.
Drug Safety|August 17, 2018
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control StudyNoel Frey, Michael Bodmer, Andreas Bircher, et al.
Pharmacoepidemiology and Drug Safety|September 3, 2024
Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims DataTamino Zappalà, Anton Pottegård, Carola A Huber, et al.
Pageof 6